Emerging Company Profile
CellPoint: bringing autologous CAR Ts to point of care
Emerging Company Profile: CellPoint aims to broaden access to CAR Ts with point-of-care manufacturing platform
With an exclusive license to Lonza’s point-of-care cell therapy manufacturing platform, CellPoint aims to bring CAR T therapies to more patients.
Jun 23, 2021 | 12:32 PM GMT
CellPoint is looking to broaden the accessibility and affordability of